Literature DB >> 27402883

A definition and ethical evaluation of overdiagnosis.

Stacy M Carter1, Chris Degeling1, Jenny Doust2, Alexandra Barratt3.   

Abstract

Overdiagnosis is an emerging problem in health policy and practice: we address its definition and ethical implications. We argue that the definition of overdiagnosis should be expressed at the level of populations. Consider a condition prevalent in a population, customarily labelled with diagnosis A. We propose that overdiagnosis is occurring in respect of that condition in that population when (1) the condition is being identified and labelled with diagnosis A in that population (consequent interventions may also be offered); (2) this identification and labelling would be accepted as correct in a relevant professional community; but (3) the resulting label and/or intervention carries an unfavourable balance between benefits and harms. We identify challenges in determining and weighting relevant harms, then propose three central ethical considerations in overdiagnosis: the extent of harm done, whether harm is avoidable and whether the primary goal of the actor/s concerned is to benefit themselves or the patient, citizen or society. This distinguishes predatory (avoidable, self-benefiting), misdirected (avoidable, other-benefiting) and tragic (unavoidable, other-benefiting) overdiagnosis; the degree of harm moderates the justifiability of each type. We end with four normative challenges: (1) methods for adjudicating between professional standards and identifying relevant harms and benefits should be procedurally just; (2) individuals, organisations and states are differently responsible for addressing overdiagnosis; (3) overdiagnosis is a matter for distributive justice: the burdens of both overdiagnosis and its prevention could fall on the least-well-off; and (4) communicating about overdiagnosis risks harming those unaware that they may have been overdiagnosed. These challenges will need to be addressed as the field develops. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Philosophy of Medicine; Public Health Ethics

Year:  2016        PMID: 27402883     DOI: 10.1136/medethics-2015-102928

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  14 in total

1.  Risk, Overdiagnosis and Ethical Justifications.

Authors:  Wendy A Rogers; Vikki A Entwistle; Stacy M Carter
Journal:  Health Care Anal       Date:  2019-12

2.  Decision curve analysis as a framework to estimate the potential value of screening or other decision-making aids.

Authors:  Michael S Martin; George A Wells; Anne G Crocker; Beth K Potter; Ian Colman
Journal:  Int J Methods Psychiatr Res       Date:  2017-12-28       Impact factor: 4.035

3.  Valuing Healthcare Improvement: Implicit Norms, Explicit Normativity, and Human Agency.

Authors:  Stacy M Carter
Journal:  Health Care Anal       Date:  2018-06

Review 4.  Overdiagnosis in primary care: framing the problem and finding solutions.

Authors:  Minal S Kale; Deborah Korenstein
Journal:  BMJ       Date:  2018-08-14

5.  Trust and medical AI: the challenges we face and the expertise needed to overcome them.

Authors:  Thomas P Quinn; Manisha Senadeera; Stephan Jacobs; Simon Coghlan; Vuong Le
Journal:  J Am Med Inform Assoc       Date:  2021-03-18       Impact factor: 4.497

Review 6.  Overdiagnosis across medical disciplines: a scoping review.

Authors:  Kevin Jenniskens; Joris A H de Groot; Johannes B Reitsma; Karel G M Moons; Lotty Hooft; Christiana A Naaktgeboren
Journal:  BMJ Open       Date:  2017-12-27       Impact factor: 2.692

7.  Overdiagnosis: An Important Issue That Demands Rigour and Precision Comment on "Medicalisation and Overdiagnosis: What Society Does to Medicine".

Authors:  Stacy M Carter
Journal:  Int J Health Policy Manag       Date:  2017-10-01

8.  On the Social Construction of Overdiagnosis Comment on "Medicalisation and Overdiagnosis: What Society Does to Medicine".

Authors:  Bjørn Hofmann
Journal:  Int J Health Policy Manag       Date:  2017-10-01

9.  Media Coverage of the Benefits and Harms of Testing the Healthy: a protocol for a descriptive study.

Authors:  Mary O'Keeffe; Alexandra Barratt; Christopher Maher; Joshua Zadro; Alice Fabbri; Mark Jones; Ray Moynihan
Journal:  BMJ Open       Date:  2019-08-24       Impact factor: 2.692

10.  The ethical, legal and social implications of using artificial intelligence systems in breast cancer care.

Authors:  Stacy M Carter; Wendy Rogers; Khin Than Win; Helen Frazer; Bernadette Richards; Nehmat Houssami
Journal:  Breast       Date:  2019-10-11       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.